LEAP 2020 – Call For Abstracts
Lightning Presentations – Lower Extremity Amputation Prevention (LEAP) Conference 2020
Conference Theme – Staying in Step: Evidence to practice change.
The Scientific Committee invites submissions of abstracts of original research in the area of the high risk foot. We are seeking presentations on areas that have a strong clinical application, and impact on clinical practice in the assessment, diagnosis and management of the high risk foot that can support clinicians to provide best practice care, and to empower and support their clients. Lightning talks are concise oral presentations of 3 minutes duration, requiring the speaker to focus on the key points of their research.
Abstracts are due no later than 5.00pm AEST, Friday 17th April 2020
Successful applicants will be notified by Monday 1st June 2020
Selection of abstracts for the Scientific Program will be made by the conference committee
Abstract Submission Guidelines:
Authors and affiliations: Authors (Arial, size 12 font. Surname, Initial. Presenting author to be in bold and italics. Affiliations number in superscript. Centred) eg Smith, B1, Doe, J2; Affiliations: (Arial, size 12, Italics font. Organisation, City, Country) eg 1 Department of General Practice, University of Melbourne, Parkville, Australia
Title (max 50 words): The title should be as brief as possible while still conveying the topic and nature of the research
Abstract body (max 250 words)
To include the headings: Background and aims; Methods; Results and Conclusions
Before writing your abstract: Consider the following:
All presenters must be registered to attend the conference. Abstract acceptance will be subject to registration for the conference. Please remember that submitting an abstract does NOT automatically register as a conference delegate. Conference registration can be completed online at a later date.
Please email your submission email@example.com no later than 5:00pm AEST, Friday 17th April 2020.
The APP-HRFG committee has submitted the following recommendations to the MBS Review Taskforce to be considered for plans to modify the MBS in relation to high risk foot services:
5.1.1 Recommendation 1
5.1.3 Recommendation 2:
Referral to a specialist may be necessary if the following is occurring:
5.1.9 Recommendation 5:
5.1.11 Recommendation 6:
6. Education, credentialing and accreditation
6.1.9 Recommendation 20:
6.1.13 Recommendation 22:
7.2.1 Recommendation 24: Development of a wound consumables scheme:
We also ask that members of the taskforce consider the following recommendations:
ANZPAC Podiatry competencies: http://www.anzpac.org.au/files/Podiatry%20Competency%20Standards%20for%20Australia%20and%20New%20Zealand%20V1.1%20211212%20(Final).pdf
International Guidelines for the prevention and management of diabetic foot disease (2019): https://iwgdfguidelines.org/
Foot Forward project (National Association of Diabetes Centres): https://nadc.net.au/foot-forward/
The MBS review into wound management has been released - please see the following link from the wound management working group:
As there are a number of areas of concern regarding HRF, the APP-HRF committee will be providing a submission to the taskforce. We welcome all members to send us your feedback by COB 10th January 2020.
Following the 2019 AGM on 22nd September the following people have been elected to the APP-HRFG Committee
Get your wound aware promotion packs from http://www.woundaware.com.au/
PoDFEd is a cross-sectional survey aiming to gather data via a 15 minute survey on the content and method of diabetes related education provided by podiatrists (Monash University ethics approval 12777)
To complete the survey, please go to:
Principal investigators of this project are:
Julia Yuncken mailto:firstname.lastname@example.org
Rene Stowlyn mailto:Rene.email@example.com
Terry Haines mailto:Terrence.firstname.lastname@example.org
Cylie Williams mailto:email@example.com
Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial
Implications of all the available evidence
Sucrose octasulfate dressings could be used in current local treatment and management of neuroischaemic diabetic foot ulcers. In the context of multidisciplinary and complex management of this condition, efficient and safe treatments that are also easy to implement by all health-care professionals are needed. Sucrose octasulfate dressings could be considered as a new standard of care.